Zelma Kiss, MD, PhD, FRCSC
Cumming School of Medicine, Department of Clinical Neurosciences
Hotchkiss Brain Institute
Hotchkiss Brain Institute, Mathison Centre for Mental Health Research and Education
Doctor of Medicine Unknown, University of Ottawa, 1988
Doctor of Philosophy Medical Specializations, University of Toronto, 1998
Zelma HT Kiss MD PhD is a clinician-scientist and Professor in the Departments of Clinical Neurosciences/Psychiatry and the Hotchkiss Brain Institute at the University of Calgary in Alberta, Canada. She trained in neurosurgery and completed a PhD in neurophysiology at the University of Toronto in 1998, followed by post-doctoral training in Grenoble, France. Her research interests encompass the mechanisms of action of deep brain stimulation, somatosensory restoration with neural prostheses, electrophysiology, and new neuromodulation therapies, including focused ultrasound. Clinical expertise includes stereotactic radiosurgery and functional neurosurgery to treat movement disorders, pain, and psychiatric disorders. She is Medical Director of the Neuromodulation and MR-guided Focused Ultrasound Programs in Calgary.
Areas of Research
Dr. Kiss’s research aims have focused on the mechanisms of action of deep brain stimulation (DBS). DBS is a neural prosthesis that modulates specific brain nuclei and pathways to restore or improve movement disorders such as Parkinson disease, dystonia and tremor. Her lab uses slice electrophysiology, behaviour, optical imaging, and immunohistochemistry in rodents to unravel how DBS works, in parallel to studies in humans who have DBS surgery. She collaborates with colleagues in biomedical engineering (Dr. Murari) to develop chronic models of DBS in rodents and veterinarian medicine (Dr. Whelan) to develop new targets for DBS. Surgery offers opportunities to study microelectrode recordings in patients undergoing DBS implantation. These include studies to look for biomarkers of disease and specific experiments to learn how different cells in the brain encode actions. Recent research has extended to the development of neural prostheses to restore somatosensory function, psychiatric indications such as depression, new neuromodulation therapies for pain, and mechanisms of focused ultrasound neuromodulation in collaboration with colleagues in radiology (Drs. Pichardo and Pike) and neurology (Drs. Aquino and Martino).
|BMEN 61931 LEC 04 04
|Spec Problems in BMEN
- Alberta Heritage Foundation for Medical Research, 2009
- Canadian Institute of Health Research Clinician Scientist Award, 2009
- salary support award, 2009
- AHFMR Clinical Investigator Renewal, 2008
- Canadian Institutes for Health Research, Clinical Research Initiative, Clinician-Scientist Phase 2 Award Renewal, 2007
- Canadian Institutes for Health Research Clinican Scientist Phase 2 Award, 2004
Are you the profile owner?
Login to edit.